DarioHealth Q1 Revenue Up 24% to $14.8M, EBITDA Loss Narrows
DRIO•DarioHealth’s Q1 revenue rose 24% year-over-year to $14.8 million, driven by a 28% increase in active subscribers to 95,000. Gross margin improved to 62%, narrowing the adjusted EBITDA loss to $1.9 million, while cash reserves of $48 million extend the runway into early 2027.
1. Revenue and Subscribers
DarioHealth reported Q1 revenue of $14.8 million, a 24% increase year-over-year, underpinned by growth in its digital health platform. Active subscriber count climbed 28% to 95,000, reflecting uptake across both employer and payer partnerships.
2. Margin Expansion and Profitability
Gross margin expanded to 62% from 55% a year earlier, as scale and platform efficiencies reduced unit costs. Adjusted EBITDA loss narrowed to $1.9 million, compared with a $2.7 million loss in Q1 2025, signaling improved operating leverage.
3. Cash Position and Runway
The company ended the quarter with $48 million in cash and equivalents, providing funding into early 2027 without additional financing. Management reaffirmed focus on cost discipline and strategic partnerships to sustain growth and move toward breakeven.
